About Us
Services
Scientific Ressources
Fields of interest
- Dermo-cosmetic
- Early drug development
Contact

About Us
Services
Scientific Ressources
Fields of interest
- Dermo-cosmetic
- Early drug development
Contact

Immune reactivity to type VII collagen: implications for gene therapy of recessive dystrophic epidermolysis bullosa.

By Synelvia 2015-12-01 Publications, Scientific resources No Comments

0 Share Tweet Share 0 Share

Immune reactivity to type VII collagen: implications for gene therapy of recessive dystrophic epidermolysis bullosa.

Next Post

Black Patients of African descent and HLA-DRB*1503 frequency Overrepresented in a French Cohort of Epidermolysis Bullosa Acquisita.

Black Patients of African descent and HLA-DRB*1503 frequency Overrepresented in a French Cohort of Epidermolysis Bullosa Acquisita.

SYNELVIA

Independent Contract Research organization
specialized in the evaluation
of drug & molecules effects
using innovative technologies
within a regulatory framework.

NEWS

Study of the antioxidant effect of White Plus Serum on UVs irradiated skin explants
Evaluation of the Anti infra-red protection of cosmetic products, In Vivo
Biochemical exploration of the cutaneous response of ultraviolet irradiation on a skin explant model

© 2019 SYNELVIA. SAS Legal mentions